Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome

Thromb Res. 2010 Jun;125(6):e275-80. doi: 10.1016/j.thromres.2010.01.031. Epub 2010 Feb 13.

Abstract

Introduction: The cortisol-induced increase in von Willebrand factor (VWF) in Cushing's syndrome (CS) seems to depend on single nucleotide polymorphisms (SNPs) of the VWF promoter, haplotype 1 (-3268G/-2709C/-2661A/-2527G) being the susceptible pattern.

Materials and methods: This study focused on a new variable region of the VWF promoter, the -2144(GT)(n) locus, to establish whether different GT-repeat lengths are also involved in modulating the cortisol-induced increase in VWF. Sixty-nine CS patients were investigated, divided into groups A (high VWF) and B (normal VWF).

Results: Analysing the (GT)(n) locus revealed a similar allele distribution in CS patients and normal subjects, (GT)(n) variants ranging from 15 to 24 repeats and (GT)(19) and (GT)(21) being the two most represented. However, when groups A and B were analysed separately, a different allele distribution was observed: short GT-repeats (15-19, GT(S)) were more frequent in group A, long GT-repeats (20-24, GT(L)) in group B (p=0.01). About genotype distributions, (GT)(S)/(GT)(S) was higher in group A and rare in group B (22.5% and 3.4%, respectively), whereas (GT)(L)/(GT)(L) was higher in group B than in group A (55.2%, 27.5%) (p=0.021). Odds-ratio analysis revealed a risk of a cortisol-dependent increase in VWF three times higher for alleles (GT)(S) than for (GT)(L), and 13-fold for genotype (GT)(S)/(GT)(S) respect to (GT)(L)/(GT)(L).

Conclusions: In conclusion, not only the SNPs haplotypes in the VWF gene promoter, but also the variable-length (GT)(n) locus predict the risk of developing high VWF levels under conditions of glucocorticoid excess; the combination of (GT)(S) and haplotype 1 represents the susceptible pattern.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Cushing Syndrome / diagnosis
  • Cushing Syndrome / genetics*
  • Cushing Syndrome / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Glucocorticoids / pharmacology*
  • Haplotypes
  • Humans
  • Male
  • Microsatellite Repeats*
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic*
  • von Willebrand Factor / drug effects
  • von Willebrand Factor / genetics*

Substances

  • Glucocorticoids
  • von Willebrand Factor